Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase II Emphasis
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Improving Mealtime Functioning in Families of Young Children with Type 1 Diabetes
Mechanism of the RNA Helicase of the Hepatitis C Virus
Development of Coping with Angry Provocation
Structure and Interactions of Proteins with Membranes
Sulindac Chemoprevention in Adenomatous Polyposis coli
Recently added grants:
Low dose IL-2 and human regulatory T cells
Host-virus interactions in the control of filovirus entry
The Effect of Maternal Cells on Infant Immunity
Complement and efferocytosis in clearing pyroptotic cells
Immunology of factor IX gene transfer to liver
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM62201-5-0-2
Application #
7568588
Study Section
Project Start
2006-01-01
Project End
2008-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Early Therapeutics Development with Phase II Emphasis
/ University of Chicago
$662,981
NIH 2007
N01 CA
Early Therapeutics Development with Phase II Emphasis
Vokes, Everett E. /
$1,737,296
NIH 2007
N01 CA
Early Therapeutics Development with Phase II Emphasis
/
$1,737,296
NIH 2007
N01 CA
Early Therapeutics Development with Phase II Emphasis
/
Comments
Be the first to comment on this grant